Also trades as: NAMSW (NASDAQ) · $vol 0M
NAMS NASDAQ
NewAmsterdam Pharma Company N.V.
1W: +2.8%
1M: -9.3%
3M: -33.5%
YTD: -34.1%
1Y: -21.0%
3Y: +154.9%
5Y: +135.5%
$23.20
-0.96 (-3.97%)
Weekly Expected Move ±8.4%
$19
$21
$23
$25
$27
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$148M
+6.8% ▲
Capital Expenditures
$246K
+63.4% ▲
5Y CAGR: +72.8%
Free Cash Flow
-$148M
+7.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$280M
-165.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$42M | -$23M | -$177M | -$242M | $0 |
| Depreciation & Amort. | $5K | $9K | $49K | $113K | $220K |
| Stock-Based Comp. | $1M | $4M | $0 | $34M | $59M |
| Change in Working Capital | $4M | $10M | $6M | -$33M | -$8M |
| Other Non-Cash Items | $7M | $19M | $30M | $82M | -$199M |
| Operating Cash Flow | -$30M | $11M | -$141M | -$159M | -$148M |
| — Investing Activities — | |||||
| Capital Expenditures | -$24K | -$221K | -$24K | -$672K | -$246K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | -$62M | -$297M |
| Investment Sales | $0 | $0 | $0 | $0 | $122M |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$24K | -$221K | -$24K | -$63M | -$175M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $747K | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$6M | $0 | $14M | $0 |
| Financing Cash Flow | $85M | $392M | $9M | $660M | $30M |
| Net Change in Cash | $50M | $408M | -$127M | $431M | -$280M |
| Cash End of Period | $60M | $468M | $340M | $772M | $491M |
| Free Cash Flow | -$30M | $10M | -$141M | -$159M | -$148M |